中外製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/03/25 | 5,910 | 5,910 | 5,811 | 5,850 | -31 | -0.5% | 2,178,700 |
2024/03/22 | 5,964 | 5,973 | 5,844 | 5,881 | -219 | -3.6% | 3,559,200 |
2024/03/21 | 6,147 | 6,153 | 6,000 | 6,100 | +40 | +0.7% | 3,096,800 |
2024/03/19 | 6,050 | 6,110 | 5,910 | 6,060 | -85 | -1.4% | 2,615,000 |
2024/03/18 | 6,010 | 6,261 | 5,996 | 6,145 | +164 | +2.7% | 2,872,100 |
2024/03/15 | 6,022 | 6,102 | 5,943 | 5,981 | -126 | -2.1% | 3,292,000 |
2024/03/14 | 6,146 | 6,197 | 6,030 | 6,107 | -112 | -1.8% | 2,560,300 |
2024/03/13 | 6,404 | 6,423 | 6,213 | 6,219 | -204 | -3.2% | 2,176,000 |
2024/03/12 | 6,430 | 6,453 | 6,380 | 6,423 | -90 | -1.4% | 2,352,700 |
2024/03/11 | 6,532 | 6,697 | 6,409 | 6,513 | -5 | -0.1% | 2,514,900 |
2024/03/08 | 6,488 | 6,573 | 6,372 | 6,518 | +83 | +1.3% | 3,827,800 |
2024/03/07 | 6,435 | 6,547 | 6,392 | 6,435 | +46 | +0.7% | 2,175,600 |
2024/03/06 | 6,317 | 6,409 | 6,254 | 6,389 | +72 | +1.1% | 2,186,800 |
2024/03/05 | 6,271 | 6,326 | 6,208 | 6,317 | +45 | +0.7% | 2,164,300 |
2024/03/04 | 6,200 | 6,283 | 6,150 | 6,272 | +163 | +2.7% | 1,921,200 |
2024/03/01 | 5,932 | 6,139 | 5,920 | 6,109 | +109 | +1.8% | 1,790,300 |
2024/02/29 | 5,901 | 6,012 | 5,886 | 6,000 | +43 | +0.7% | 2,401,300 |
2024/02/28 | 5,950 | 6,046 | 5,891 | 5,957 | -43 | -0.7% | 1,795,200 |
2024/02/27 | 5,936 | 6,059 | 5,926 | 6,000 | -8 | -0.1% | 2,673,300 |
2024/02/26 | 5,712 | 6,008 | 5,705 | 6,008 | +360 | +6.4% | 3,223,700 |
2024/02/22 | 5,855 | 5,882 | 5,288 | 5,648 | -242 | -4.1% | 5,166,600 |
2024/02/21 | 5,981 | 6,043 | 5,855 | 5,890 | +48 | +0.8% | 2,172,400 |
2024/02/20 | 5,797 | 5,921 | 5,765 | 5,842 | +63 | +1.1% | 1,860,000 |
2024/02/19 | 5,925 | 5,950 | 5,745 | 5,779 | -125 | -2.1% | 1,649,000 |
2024/02/16 | 5,798 | 5,972 | 5,793 | 5,904 | +199 | +3.5% | 3,169,000 |
2024/02/15 | 5,720 | 5,742 | 5,653 | 5,705 | +59 | +1% | 2,040,200 |
2024/02/14 | 5,700 | 5,743 | 5,623 | 5,646 | -76 | -1.3% | 2,128,700 |
2024/02/13 | 5,542 | 5,733 | 5,518 | 5,722 | +271 | +5% | 3,091,600 |
2024/02/09 | 5,444 | 5,550 | 5,421 | 5,451 | +31 | +0.6% | 3,591,300 |
2024/02/08 | 5,171 | 5,421 | 5,171 | 5,420 | +227 | +4.4% | 3,299,400 |
2024/02/07 | 5,085 | 5,245 | 5,075 | 5,193 | +65 | +1.3% | 1,890,400 |
2024/02/06 | 5,090 | 5,150 | 5,061 | 5,128 | +4 | +0.1% | 2,485,400 |
2024/02/05 | 5,210 | 5,213 | 5,043 | 5,124 | -62 | -1.2% | 3,089,700 |
2024/02/02 | 5,261 | 5,345 | 5,084 | 5,186 | -124 | -2.3% | 3,789,600 |
2024/02/01 | 5,332 | 5,375 | 5,267 | 5,310 | -37 | -0.7% | 1,759,000 |
2024/01/31 | 5,297 | 5,358 | 5,280 | 5,347 | -23 | -0.4% | 2,235,200 |
2024/01/30 | 5,490 | 5,501 | 5,330 | 5,370 | -80 | -1.5% | 1,871,000 |
2024/01/29 | 5,450 | 5,502 | 5,433 | 5,450 | +34 | +0.6% | 1,461,900 |
2024/01/26 | 5,450 | 5,485 | 5,401 | 5,416 | -39 | -0.7% | 1,636,300 |
2024/01/25 | 5,474 | 5,512 | 5,383 | 5,455 | -119 | -2.1% | 2,059,000 |
2024/01/24 | 5,583 | 5,607 | 5,526 | 5,574 | -52 | -0.9% | 1,335,700 |
2024/01/23 | 5,581 | 5,705 | 5,576 | 5,626 | +28 | +0.5% | 1,479,500 |
2024/01/22 | 5,613 | 5,650 | 5,544 | 5,598 | +57 | +1% | 1,882,000 |
2024/01/19 | 5,645 | 5,677 | 5,497 | 5,541 | -92 | -1.6% | 2,193,500 |
2024/01/18 | 5,667 | 5,705 | 5,620 | 5,633 | -76 | -1.3% | 2,114,000 |
2024/01/17 | 5,869 | 5,920 | 5,709 | 5,709 | -207 | -3.5% | 3,403,800 |
2024/01/16 | 5,928 | 5,974 | 5,887 | 5,916 | -19 | -0.3% | 1,412,500 |
2024/01/15 | 5,892 | 5,968 | 5,841 | 5,935 | +48 | +0.8% | 1,644,500 |
2024/01/12 | 6,035 | 6,035 | 5,868 | 5,887 | +52 | +0.9% | 3,904,100 |
2024/01/11 | 5,781 | 5,865 | 5,756 | 5,835 | +167 | +2.9% | 2,785,800 |
301~
350
件表示中 / 3721件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
中外薬 | 746,200円 | +1.7% | +5.0% | 3.35% | 29.95倍 | 6.46倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
武 田 | 433,600円 | -1.1% | +75.3% | 4.61% | 29.70倍 | 0.98倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
第一三共 | 349,500円 | +6.0% | +4.0% | 2.23% | 21.70倍 | 4.01倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
大塚HD | 721,300円 | +2.2% | +10.2% | 1.66% | 13.85倍 | 1.39倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 138,500円 | +0.9% | +380.2% | 5.63% | 19.07倍 | 1.64倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム